Jump to content

Marco Baggiolini: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Ticino100 (talk | contribs)
69 edits
Removed nations from awards.
Ticino100 (talk | contribs)
69 edits
A few words on the importance of chemokines.
Line 1: Line 1:
{{Short description|Swiss immunologist}}
{{Short description|Swiss immunologist}}
'''Marco Baggiolini''' (* [[August 1]] [[1936]] in [[Bellinzona]])<ref name = "cv">Presidenti passati USI (27 November 2016). [https://www.usi.ch/it/universita/chi-siamo/storia/presidenti-passati Biography of Marco Baggiolini]. ''[[Università della Svizzera italiana]]''. Accessed August 2021.</ref> is a Swiss [[immunology|immunologist]] and biochemist known for the discovery and the analysis of the first [[chemokine]]s (or '''chemo'''tactic cyto'''kines''').<ref>{{Cite web|last=GmbH|first=Avoxa-Mediengruppe Deutscher Apotheker|title=Robert-Koch-Preis geht an amerikanischen Mikrobiologen|url=https://www.pharmazeutische-zeitung.de/inhalt-44-2000/medizin5-44-2000/|url-status=live|access-date=2021-08-21|website=Pharmazeutische Zeitung online|language=de|quote=... ließ Marco Baggiolini, Direktor am Theodor-Kocher-Institut der Berner Universität, aufhorchen. "Das müssen wir checken" sagte er und entdeckte vor rund 13 Jahren ein neues Protein, das Interleukin-8. Es war das erste von mittlerweile mehr als 50 Chemokinen. {{!}} This made Marco Baggiolini, director at the Theodor Kocher Institute at Bern University, sit up. "We have to check that," he said and discovered a new protein, interleukin-8, around 13 years ago. It was the first of more than 50 chemokines.}}</ref> For his work he has received awards including the prize of the Society for Leukocyte Biology (1988),<ref name = "leukocyte">SLB Legacy Keynote Lecture Award. [https://www.leukocytebiology.org/slb-legacy-award Previous Award Winners: Marco Baggiolini (1988)]. ''Society for Leukocyte Biology''. Accessed August 2021.</ref> the Emil von Behring Prize (1998),<ref name = "behring">Auszeichnungen und Preise der Philipps-Universität Marburg [https://www.uni-marburg.de/de/universitaet/profil/preise/auszeichnungen Emil von Behring Prize: Previous Award Winners: 1998 Prof. Dr. Marco Baggiolini, Bern]. ''[[Philipps-Universität Marburg]]''. Accessed August 2021.</ref> and the [[Robert Koch Medal]] (2000).<ref name = "koch">Robert-Koch-Stiftung [https://www.robert-koch-stiftung.de/en/awards/laureates Laureates A - Z: Marco Baggiolini (2000)]. ''[[Robert Koch]] Foundation''. Accessed August 2021.</ref>
'''Marco Baggiolini''' (* [[August 1]] [[1936]] in [[Bellinzona]])<ref name = "cv">Presidenti passati USI (27 November 2016). [https://www.usi.ch/it/universita/chi-siamo/storia/presidenti-passati Biography of Marco Baggiolini]. ''[[Università della Svizzera italiana]]''. Accessed August 2021.</ref> is a Swiss [[immunology|immunologist]] and biochemist known for the discovery and the analysis of the first [[chemokine]]s (or '''chemo'''tactic cyto'''kines''').<ref>{{Cite web|last=GmbH|first=Avoxa-Mediengruppe Deutscher Apotheker|title=Robert-Koch-Preis geht an amerikanischen Mikrobiologen|url=https://www.pharmazeutische-zeitung.de/inhalt-44-2000/medizin5-44-2000/|url-status=live|access-date=2021-08-21|website=Pharmazeutische Zeitung online|language=de|quote=... ließ Marco Baggiolini, Direktor am Theodor-Kocher-Institut der Berner Universität, aufhorchen. "Das müssen wir checken" sagte er und entdeckte vor rund 13 Jahren ein neues Protein, das Interleukin-8. Es war das erste von mittlerweile mehr als 50 Chemokinen. {{!}} This made Marco Baggiolini, director at the Theodor Kocher Institute at Bern University, sit up. "We have to check that," he said and discovered a new protein, interleukin-8, around 13 years ago. It was the first of more than 50 chemokines.}}</ref>
Chemokines act as chemoattractants to guide the migration of cells. Some control cells of the [[immune system]], some promote the growth of new [[blood vessel]]s, some cause [[inflammation]] in response to [[bacteria]]l infection and [[virus]]es, for example, to activate cells to initiate an immune response or promote [[wound healing]]. For his work he has received awards including the prize of the Society for Leukocyte Biology (1988),<ref name = "leukocyte">SLB Legacy Keynote Lecture Award. [https://www.leukocytebiology.org/slb-legacy-award Previous Award Winners: Marco Baggiolini (1988)]. ''Society for Leukocyte Biology''. Accessed August 2021.</ref> the Emil von Behring Prize (1998),<ref name = "behring">Auszeichnungen und Preise der Philipps-Universität Marburg [https://www.uni-marburg.de/de/universitaet/profil/preise/auszeichnungen Emil von Behring Prize: Previous Award Winners: 1998 Prof. Dr. Marco Baggiolini, Bern]. ''[[Philipps-Universität Marburg]]''. Accessed August 2021.</ref> and the [[Robert Koch Medal]] (2000).<ref name = "koch">Robert-Koch-Stiftung [https://www.robert-koch-stiftung.de/en/awards/laureates Laureates A - Z: Marco Baggiolini (2000)]. ''[[Robert Koch]] Foundation''. Accessed August 2021.</ref>


Baggiolini studied medicine at the [[University of Basel]], graduating in 1962.<ref name = "cv" /> Then he worked as an assistant in biochemistry at the [[University of Bern]] (1963-1967) and as a research associate at [[Rockefeller University]] in New York (1967-1970) in the laboratory of [[Christian de Duve]] ([[Nobel Prize]] in 1974).<ref name = "cv" /> He was an active researcher at the [[Sandoz]] Group in Basel from 1970 to 1983, where he served as deputy director of the Division of [[Pharmacology]] and [[Toxicology]] (1977-1979) and director of the Division of Research on [[Inflammation]] and [[Immunology]] (1979-1983).<ref name = "cv" /> In 1983 he was appointed as director of the [[Theodor Kocher]] Institute at the [[University of Bern]], where he inaugurated a new research program on inflammation. He received a honorary degree in medicine from the [[University of Ferrara]]. He was appointed as honorary member of the Swiss Academy of Medical Sciences and as member of the [[Academia Europaea]].<ref name="cv" /><ref>{{Cite web|title=Academy of Europe: Baggiolini Marco|url=https://www.ae-info.org/ae/Member/Baggiolini_Marco|access-date=2021-08-21|website=www.ae-info.org}}</ref> He was a member of the editorial boards of American and European scientific journals, as well as several scientific societies and scientific and cultural foundations. In 1996, he became the founding president of the [[University of Italian Switzerland|Università della Svizzera Italiana]] (USI).<ref name = "cv" />
Baggiolini studied medicine at the [[University of Basel]], graduating in 1962.<ref name = "cv" /> Then he worked as an assistant in biochemistry at the [[University of Bern]] (1963-1967) and as a research associate at [[Rockefeller University]] in New York (1967-1970) in the laboratory of [[Christian de Duve]] ([[Nobel Prize]] in 1974).<ref name = "cv" /> He was an active researcher at the [[Sandoz]] Group in Basel from 1970 to 1983, where he served as deputy director of the Division of [[Pharmacology]] and [[Toxicology]] (1977-1979) and director of the Division of Research on [[Inflammation]] and [[Immunology]] (1979-1983).<ref name = "cv" /> In 1983 he was appointed as director of the [[Theodor Kocher]] Institute at the [[University of Bern]], where he inaugurated a new research program on inflammation. He received a honorary degree in medicine from the [[University of Ferrara]]. He was appointed as honorary member of the Swiss Academy of Medical Sciences and as member of the [[Academia Europaea]].<ref name="cv" /><ref>{{Cite web|title=Academy of Europe: Baggiolini Marco|url=https://www.ae-info.org/ae/Member/Baggiolini_Marco|access-date=2021-08-21|website=www.ae-info.org}}</ref> He was a member of the editorial boards of American and European scientific journals, as well as several scientific societies and scientific and cultural foundations. In 1996, he became the founding president of the [[University of Italian Switzerland|Università della Svizzera Italiana]] (USI).<ref name = "cv" />

Revision as of 15:12, 23 August 2021

Marco Baggiolini (* August 1 1936 in Bellinzona)[1] is a Swiss immunologist and biochemist known for the discovery and the analysis of the first chemokines (or chemotactic cytokines).[2] Chemokines act as chemoattractants to guide the migration of cells. Some control cells of the immune system, some promote the growth of new blood vessels, some cause inflammation in response to bacterial infection and viruses, for example, to activate cells to initiate an immune response or promote wound healing. For his work he has received awards including the prize of the Society for Leukocyte Biology (1988),[3] the Emil von Behring Prize (1998),[4] and the Robert Koch Medal (2000).[5]

Baggiolini studied medicine at the University of Basel, graduating in 1962.[1] Then he worked as an assistant in biochemistry at the University of Bern (1963-1967) and as a research associate at Rockefeller University in New York (1967-1970) in the laboratory of Christian de Duve (Nobel Prize in 1974).[1] He was an active researcher at the Sandoz Group in Basel from 1970 to 1983, where he served as deputy director of the Division of Pharmacology and Toxicology (1977-1979) and director of the Division of Research on Inflammation and Immunology (1979-1983).[1] In 1983 he was appointed as director of the Theodor Kocher Institute at the University of Bern, where he inaugurated a new research program on inflammation. He received a honorary degree in medicine from the University of Ferrara. He was appointed as honorary member of the Swiss Academy of Medical Sciences and as member of the Academia Europaea.[1][6] He was a member of the editorial boards of American and European scientific journals, as well as several scientific societies and scientific and cultural foundations. In 1996, he became the founding president of the Università della Svizzera Italiana (USI).[1]

Baggiolini also directed Division IV of the Swiss National Science Foundation, responsible for the National Centers of Competence in Research and the National Programs. He was also co-director of the Swiss National Supercomputing Centre at ETH Zurich (CSCS).[7]

References

  1. ^ a b c d e f Presidenti passati USI (27 November 2016). Biography of Marco Baggiolini. Università della Svizzera italiana. Accessed August 2021.
  2. ^ GmbH, Avoxa-Mediengruppe Deutscher Apotheker. "Robert-Koch-Preis geht an amerikanischen Mikrobiologen". Pharmazeutische Zeitung online (in German). Retrieved 2021-08-21. ... ließ Marco Baggiolini, Direktor am Theodor-Kocher-Institut der Berner Universität, aufhorchen. "Das müssen wir checken" sagte er und entdeckte vor rund 13 Jahren ein neues Protein, das Interleukin-8. Es war das erste von mittlerweile mehr als 50 Chemokinen. | This made Marco Baggiolini, director at the Theodor Kocher Institute at Bern University, sit up. "We have to check that," he said and discovered a new protein, interleukin-8, around 13 years ago. It was the first of more than 50 chemokines.{{cite web}}: CS1 maint: url-status (link)
  3. ^ SLB Legacy Keynote Lecture Award. Previous Award Winners: Marco Baggiolini (1988). Society for Leukocyte Biology. Accessed August 2021.
  4. ^ Auszeichnungen und Preise der Philipps-Universität Marburg Emil von Behring Prize: Previous Award Winners: 1998 Prof. Dr. Marco Baggiolini, Bern. Philipps-Universität Marburg. Accessed August 2021.
  5. ^ Robert-Koch-Stiftung Laureates A - Z: Marco Baggiolini (2000). Robert Koch Foundation. Accessed August 2021.
  6. ^ "Academy of Europe: Baggiolini Marco". www.ae-info.org. Retrieved 2021-08-21.
  7. ^ ETH Life on Baggiolini's appointment as co-director
Retrieved from "https://en.wikipedia.org/w/index.php?title=Marco_Baggiolini&oldid=1040264111"